Does INGENOL MEBUTATE Cause Application site swelling? 489 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 489 reports of Application site swelling have been filed in association with INGENOL MEBUTATE. This represents 16.2% of all adverse event reports for INGENOL MEBUTATE.
489
Reports of Application site swelling with INGENOL MEBUTATE
16.2%
of all INGENOL MEBUTATE reports
0
Deaths
7
Hospitalizations
How Dangerous Is Application site swelling From INGENOL MEBUTATE?
Of the 489 reports, 7 (1.4%) required hospitalization, and 2 (0.4%) were considered life-threatening.
Is Application site swelling Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INGENOL MEBUTATE. However, 489 reports have been filed with the FAERS database.
What Other Side Effects Does INGENOL MEBUTATE Cause?
Application site erythema (1,373)
Application site pain (1,012)
Application site vesicles (843)
Application site exfoliation (586)
Drug administered at inappropriate site (500)
Application site scab (451)
Application site dryness (365)
Incorrect drug administration duration (339)
Application site pruritus (291)
Inappropriate schedule of drug administration (250)
What Other Drugs Cause Application site swelling?
NICOTINE (431)
SUMATRIPTAN (191)
ESTRADIOL (134)
BUPRENORPHINE (110)
DICLOFENAC (90)
ESTRADIOL\NORETHINDRONE (90)
DOCOSANOL (86)
MINOXIDIL (85)
METHYLPHENIDATE (80)
CRISABOROLE (78)
Which INGENOL MEBUTATE Alternatives Have Lower Application site swelling Risk?
INGENOL MEBUTATE vs INLYTA
INGENOL MEBUTATE vs INOTERSEN
INGENOL MEBUTATE vs INOTUZUMAB OZOGAMICIN
INGENOL MEBUTATE vs INSULIN
INGENOL MEBUTATE vs INSULIN ASPART